Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Dapaquest M 5mg/500mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Morepen Laboratories Ltd

Salt Composition

Dapagliflozin (5mg) + Metformin (500mg)

Overview Dapaquest M 5mg/500mg Tablet ER

DapiComb 5mg/500mg Extended-Release Tablets combine two medications to manage type 2 diabetes. This treatment helps regulate elevated blood glucose, lessening the likelihood of serious diabetic complications and contributing to heart disease prevention. DapiComb 5mg/500mg ER tablets can be taken with food, consistently at the same time daily for optimal adherence. Dosage is determined by your physician; cessation requires medical consultation to avoid potential blood sugar spikes and complications such as kidney impairment or vision loss. This medication is a component of a comprehensive diabetes management plan, incorporating a healthy diet, regular physical activity, and weight management as directed by your doctor. Common side effects include pharyngitis, rhinitis, nasal congestion, cephalalgia, nausea, emesis, and diarrhea. Adequate hydration is crucial to prevent dehydration. Genital fungal infections are a possibility; maintaining good hygiene is recommended for prevention. Prior to use, inform your doctor of any kidney or liver dysfunction, urinary tract infections, or diuretic use. Pregnant or lactating individuals should seek medical advice before commencing treatment. Limit alcohol consumption to mitigate potential side effect exacerbation. Regular blood glucose monitoring is essential during treatment.

Uses of Dapaquest M 5mg/500mg Tablet ER

Managing type 2 diabetes

Major Benefits of Dapaquest M 5mg/500mg Tablet ER:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the entire tablet; avoid chewing, crushing, or breaking it. Consume Dapaquest M 5mg/500mg Extended-Release tablets with food.

Common Side effects of Dapaquest M 5mg/500mg Tablet ER:

  • Nausea
  • Vomiting
  • Diarrhea
  • Genital fungal infection
  • Nasopharyngitis (inflammation of the throat and nasal passages)
  • Urinary tract infection
  • Polyuria
  • Flatulence
  • Skin rash
  • Taste change
  • Difficulty in urination
  • Hypoglycemia (low blood glucose level)
  • Tremors
  • Dizziness
  • Back pain
  • Increased hematocrit
  • Decreased creatinine clearance
  • Dyslipidemia

How to use Dapaquest M 5mg/500mg Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for Dapaquest M 5mg/500mg Extended-Release Tablets. Ingest the tablets whole; do not break, crush, or chew them. Administer this medication with food.

How Dapaquest M 5mg/500mg Tablet ER works:

Dapagliflozin and Metformin, combined as Dapaquest M 5mg/500mg Extended-Release tablets, offer enhanced blood glucose management. Dapagliflozin facilitates urinary glucose excretion, while Metformin reduces hepatic glucose production, slows intestinal glucose uptake, and improves insulin responsiveness. This dual-action approach leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Dapaquest M 5mg/500mg ER tablets with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Dapaquest M 5mg/500mg tablet might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Dapaquest M 5mg/500mg tablets are likely unsafe for breastfeeding mothers. Available human data indicate potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Impaired driving is possible with excessively high or low blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Exercise caution when administering Dapaquest M 5mg/500mg Extended-Release tablets to individuals with impaired renal function. Dosage modification of Dapaquest M 5mg/500mg Extended-Release tablets may be necessary. Physician consultation is recommended.

LiverLiverCAUTION

Patients with liver impairment should use Dapaquest M 5mg/500mg Extended-Release tablets cautiously. Dosage modification may be necessary; physician consultation is advised.

What if you forget to take Dapaquest M 5mg/500mg Tablet ER :

Should you forget a Dapaquest M 5mg/500mg Extended-Release Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Dapaquest M 5mg/500mg Tablet ER

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management
Dapaquest M 5mg/500mg Tab...
60
MRP 70
14% off